Oncology ImagingArchives
Integrating PET/CT into breast cancer care: a review of recent developments
Oncology Imaging 1 min.
Breast cancer (BC) is the most common malignancy in women, classified by histopathological type, grade, receptor status, and stage. PET/CT, particularly with F-FDG, plays a vital role in staging, detecting metastases, and assessing treatment response. This review explores the role of PET/CT in BC management...
Differentiated thyroid cancer and positron emission computed tomography: when, how and why?
Oncology Imaging 1 min.
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has become an indispensable tool in oncology, offering both metabolic and anatomical insights into tumor behavior. Most differentiated thyroid carcinomas (DTC) are indolent and therefore FDG PET/CT is not routinely incorporated...
Validation of the PSMA PRIMARY Scoring System and Comparison to an E-PSMA Likert System for [68Ga]Ga-PSMA-11 PET/CT Interpretation in Men With Suspected Radiorecurrent Prostate Cancer.
Oncology Imaging 1 min.
To validate the recently published 5-point PRIMARY scoring system against a 5-point European Association of Nuclear Medicine (E-PSMA) Likert system for the detection of intraprostatic recurrence for patients undergoing [68Ga]Ga-PSMA-11 PET/CT who have previously received radiotherapy for prostate cancer...
Continuous-time random walk diffusion MRI facilitates assessment of Ki-67 expression in endometrial cancer: a comparative study with diffusion kurtosis imaging
Oncology Imaging 4 min.
Endometrial carcinoma (EC), acknowledged among the most aggressive malignancies affecting the female reproductive tract, demonstrates progressively increasing incidence and mortality rates [1]. Ki-67, a chromatin-associated nuclear protein critical for maintaining structural integrity during cellular...
